AI chatbot to screen for hereditary cancer risk in Singaporeans

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study tests a chatbots’ ability to screen for hereditary cancer risk in both the general public and cancer patients in Singapore. The team will measure how often the system can complete the screening and how accurate its preliminary risk assessment is compared with standard methods. Participants will complete a survey after using the chatbot to gauge usability and perceived usefulness. The study aims to inform future integration of AI-assisted genetic risk screening into clinical practice. It is conducted at the National Cancer Centre Singapore with collaboration from Kanagawa University of Human Services.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Singapore citizen or permanent resident
* Individuals from the general public or patients at NCCS
* Adults (aged 21 or older) who are capable of giving informed consent

Exclusion Criteria:

* Under the age of 21 years old
* Incapable of giving informed consent

Where it's running

• National Cancer Center Singapore
  Singapore, Singapore Recruiting

Study contacts

• Principal investigator: Dr Joanne Ngeow, MBBS, MRCP, MPH, PhD — National Cancer Centre, Singapore
• Study coordinator: Dr Joanne Ngeow, MBBS, MRCP, MPH, PhD
• Email: joanne.ngeow.y.y@singhealth.com.sg
• Phone: +65 6306 5904

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Self‑report questionnaire to spot inherited cancer risk in children and teens

  This project will test whether a caregiver- or patient-completed questionnaire plus a short pre-visit brochure can help identify children and adolescents with an inherited cancer predisposition and improve caregiver genetics knowledge and satisfaction.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern · NCT07378423

• Combined carrier and hereditary cancer screening offered during pregnancy or preconception

  This project will test if pregnant and preconception patients will choose hereditary cancer genetic testing when it's offered alongside routine carrier screening.

  Recruiting at 4 sites Weill Medical College of Cornell University · Brooklyn, New York and 4 other locations · NCT07052266

• Identifying new targets for reducing colorectal and endometrial cancer risk

  This study is trying to find new ways to lower the risk of colorectal and endometrial cancer by looking at genetic information and family histories from patients who have been screened for these cancers.

  Recruiting Weill Medical College of Cornell University · New York, New York · NCT06096688

• Collection of blood and tissue samples from patients with suspected or confirmed cancer

  This study is collecting blood and tissue samples from patients with suspected or confirmed cancer to help researchers learn more about how these cancers develop and find new treatment options.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT00026884

• Testing for cancer risk genes in children with newly diagnosed cancer

  This study is testing whether a family-based genetic test can help find cancer risk genes in children and teens who have just been diagnosed with cancer.

  Recruiting at 3 sites Sydney Children's Hospitals Network · Newcastle, New South Wales and 2 other locations · NCT04903782

• Ilaris for periodic fever syndromes and systemic juvenile idiopathic arthritis in Korea

  This will test how safe and effective Ilaris is for children and adults in Korea who are being treated for hereditary periodic fever syndromes or systemic juvenile idiopathic arthritis.

  Recruiting Novartis · Seoul · NCT06838143

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.